This federal contract award, valued at $7,832.28, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order (DO) for the supply of Candesartan Cilexetil 32 mg tablets, a cardiovascular medication, with a completion date of November 6, 2024. The contract has a Firm Fixed Price (FFP) pricing type and was not designated with any set-aside requirements, indicating open competition.
Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that supplies medical products to various federal government agencies, including the DLA Troop Support Medical. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, Amerisourcebergen maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000, for similar medical products and prescription drugs.
Generated 2/4/25, 10:36 AM